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Original ArticleA role for long-chain acyl-CoA synthetase-4
(ACSL4) in diet-induced phospholipid remodeling
and obesity-associated adipocyte dysfunctionElizabeth A. Killion 1,2, Andrew R. Reeves 1, Mahmoud A. El Azzouny 3, Qing-Wu Yan 1, Defne Surujon 1,
John D. Griffin 1,2, Thomas A. Bowman 1, Chunyan Wang 4, Nirupa R. Matthan 1,2, Eric L. Klett 5, Dong Kong 6,
John W. Newman 7, Xianlin Han 4, Mi-Jeong Lee 8, Rosalind A. Coleman 9, Andrew S. Greenberg 1,2,*ABSTRACT
Objective: Regulation of fatty acid (FA) metabolism is central to adipocyte dysfunction during diet-induced obesity (DIO). Long-chain acyl-CoA
synthetase-4 (ACSL4) has been hypothesized to modulate the metabolic fates of polyunsaturated FA (PUFA), including arachidonic acid (AA), but
the in vivo actions of ACSL4 are unknown. The purpose of our studies was to determine the in vivo role of adipocyte ACSL4 in regulating obesity-
associated adipocyte dysfunction.
Methods: We developed a novel mouse model with adipocyte-specific ablation of ACSL4 (Ad-KO) using loxP Cre recombinase technology.
Metabolic phenotyping of Ad-KO mice relative to their floxed littermates (ACSL4floxed) was performed, including body weight and body composition
over time; insulin and glucose tolerance tests; and energy expenditure, activity, and food intake in metabolic cages. Adipocytes were isolated for
ex vivo adipocyte oxygen consumption by Clark electrode and lipidomics analysis. In vitro adipocyte analysis including oxygen consumption by
Seahorse and real-time PCR analysis were performed to confirm our in vivo findings.
Results: Ad-KO mice were protected against DIO, adipocyte death, and metabolic dysfunction. Adipocytes from Ad-KO mice fed high-fat diet
(HFD) had reduced incorporation of AA into phospholipids (PL), free AA, and levels of the AA lipid peroxidation product 4-hydroxynonenal (4-HNE).
Additionally, adipocytes from Ad-KO mice fed HFD had reduced p53 activation and increased adipocyte oxygen consumption (OCR), which we
demonstrated are direct effects of 4-HNE on adipocytes in vitro.
Conclusion: These studies are the first to elucidate ACSL4’s in vivo actions to regulate the incorporation of AA into PL and downstream effects on
DIO-associated adipocyte dysfunction. By reducing the incorporation of AA into PL and free fatty acid pools in adipocytes, Ad-KO mice were
significantly protected against HFD-induced increases in adipose and liver fat accumulation, adipocyte death, gonadal white adipose tissue
(gWAT) inflammation, and insulin resistance (IR). Additionally, deficiency of adipocyte ACSL4 expression in mice fed a HFD resulted in increased
gWAT adipocyte OCR and whole body energy expenditure (EE).
 2018 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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The prevalence of obesity, a condition which predisposes to the
development of type 2 diabetes mellitus (T2DM), in the United States
is approximately 35% in the adult population [1]. While the vast
majority of obese individuals are afflicted with metabolic complica-
tions, not all such individuals develop these health problems [2].
These observations raise the fundamentally important question of
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Original Articletriacylglycerol (TAG), as well as proteins that convert FA into a variety
of bioactive lipid mediators. Polyunsaturated FA (PUFA) have multiple
fates, including incorporation into PL, TAG, and cholesterol ester, and
oxygenation by enzymatic (cyclooxygenase, lipoxygenase, cyto-
chrome P450) and non-enzymatic mechanisms, specifically peroxi-
dation of lipids by reactive oxygen species (ROS) to form aldehydes,
such as 4-hydroxynonenal (4-HNE), that can detrimentally alter
cellular metabolism [5,6].
The long-chain acyl-CoA synthetase (ACSL) family of enzymes catalyze
the addition of a coenzyme-A (CoA) group to a FA to form fatty acyl-
CoAs, effectively “trapping” FAs within cells [7,8]. Five ACSL iso-
forms can each activate and channel various FAs to different metabolic
fates [7]. ACSL1 is the most abundant isoform expressed in white
adipose tissue (WAT) and accounts for 80% of total ACSL activity in
WAT [9,10]. ACSL4 is expressed at a significantly lower level in adi-
pocytes compared to ACSL1, but its role in adipocyte metabolism and
obesity is unknown. Interestingly, ACSL4 is the only ACSL isoform
whose enzymatic activity is directly inhibited by the class of anti-
diabetic drugs thiazolidinediones (TZDs) through PPAR-g-indepen-
dent mechanisms, suggesting ACSL4’s possible involvement in
regulation of metabolism [11,12]. Additionally, ACSL4 has a signifi-
cantly greater in vitro preference for arachidonic acid (AA) and eico-
sapentanoic acid (EPA) as compared to other long-chain saturated and
unsaturated FA, with a lower preference for stearic, palmitic, and
linoleic acid (LA) as well [13]. Proposed functions of ACSL4 include
intracellular lipid storage [14], cholesterol transport from the endo-
plasmic reticulum into the mitochondria [15], and regulation of AA and
its metabolites [13,16e18]. More recently, ACSL4 was demonstrated
to be essential for the increased rates of lipid peroxidation necessary
for ferroptosis, a specific mode of iron-dependent, non-apoptotic cell
death [19e21].
The purpose of our studies was to determine the role of ACSL4 in
regulating obesity-associated adipocyte dysfunction. To fulfill this
objective, we used LoxP-Cre technology to generate a novel mouse
model that specifically ablated ACSL4 in adipocytes in order to char-
acterize in vivo mechanisms of ACSL4’s effects in adipocytes during
diet-induced obesity (DIO). This work presents the first in vivo eluci-
dation of ACSL4’s actions. In the context of DIO, adipocyte ACSL4
regulates adiposity, obesity-associated inflammation and metabolic
complications, whole-body energy expenditure (EE), and isolated
adipocyte oxygen consumption rate (OCR). Here we demonstrate that
with DIO, gWAT adipocyte ACSL4 modulates AA in the free fatty acid
(FFA) pool and incorporation into PL and promotes the production of the
lipid peroxidation product 4-HNE.
2. MATERIALS AND METHODS
2.1. Generation of mice that lack ACSL4 specifically in adipocytes
Adipocyte-specific ACSL4 knockout mice (Ad-KO) were created using
LoxP-Cre technology [22]. The gene-targeting vector was designed to
produce a floxed ACSL4 gene on the X chromosome with loxP sites on
either side of exons 3e4 at the University of North Carolina Animal
Models Core using previously described methods [22]. The vector
was constructed in a standard plasmid backbone containing
neomycin phosphotransferase (neo) and thymidine kinase cassettes
for positive and negative selection, respectively [22]. The targeting
vector was electroporated into E14Tg2A (E14) embryonic stem cells,
and the cells were grown in medium supplemented with G418 and
ganciclovir [22]. Targeted cells were identified by PCR across both
the 30 and 50 arms of homology using primers specific to neo and
primers flanking the arms of homology. Targeted, neomycin-resistant44 MOLECULAR METABOLISM 9 (2018) 43e56  2018 The Authors. Published by Elsevier GmbH. Tcells were microinjected into blastocysts derived from mouse strain
129SJ to produce transmitting chimeras. Neo was then excised from
the targeted allele by mating to mice expressing FLPo recombinase
[23]. Mice homozygous for the targeted allele (Acsl4flox/Y) were
identified by genotyping PCR and back-crossed six times to C57BL/6
mice. Heterozygous Acsl4flox/þ female and floxed male Acsl4flox/Y
mice were sent to the Jean Mayer-U.S. Department of Agriculture
Human Nutrition Research Center on Aging at Tufts University. DNA
from these mice was sent to Charles River for C57BL/6J congenic
analysis and the female and male with the greatest percentage of
C57BL/6J microsatellite analysis (>99%) were mated together. From
the progeny of this breeding pair, floxed male mice (Acsl4flox/Y) were
then crossed with female C57BL/6 mice (Acsl4þ/þ) in which Cre
expression is driven by the Adiponectin promoter purchased from
Jackson Laboratories [B6; FVB-Tg (Adipoq-cre)1Evdr/J; Jackson
Laboratories, Bar Harbor, ME] [24]. The next generation of progeny
were produced by mating Acsl4flox/þ/Cre þ females to Acsl4flox/Y/
Cre-males, and then subsequent matings to generate experimental
mice were either between Acsl4flox/Y/Cre-males (ACSL4floxed) &
Acsl4flox/flox/Cre þ females (Ad-KO) or Acsl4flox/Y/Cre þ males (Ad-
KO) & Acsl4flox/flox/Cre-females (ACSL4floxed), which consistently
yields equal numbers of males and females with (Ad-KO) and without
Adipoq-Cre (ACSL4floxed).
2.2. Animal care and in vivo analysis
Experiments were conducted in a viral pathogen-free facility at the
Jean Mayer U.S. Department of Agriculture Human Nutrition Research
Center on Aging at Tufts University in accordance with Institutional
Animal Care and Use Committees guidelines. All experimental Ad-KO
and littermate ACSL4floxed mice were male. Mice were weaned at
3e4 weeks of age and fed ad libitum a purified standard chow diet
(Teklad 2016S). Mice were individually caged at 6e7 weeks of age. At
8 weeks old, mouse body weight and body composition were
measured by magnetic resonance (EchoMRI-700) and then mice were
randomized to receive either a high-fat diet (HFD) containing 60% kcal
from fat or a low-fat diet (LFD) containing 10% kcal from fat (Research
Diets D12492 and D12450J, respectively) ad libitum for 12 weeks.
Previous work has determined that 12 weeks on 60% HFD is the
optimal amount of time for the greatest increase in adipocyte size,
macrophage infiltration into WAT, and expression of pro-inflammatory
cytokines without an increase in dead adipocytes that occurs with 16
weeks on 60% HFD [25,26]. Body weight and body composition were
measured every 2e4 weeks as indicated.
Mice were randomly selected for indirect calorimetry (TSE Systems) in
metabolic cages to evaluate oxygen consumption, carbon dioxide
production, food intake, and activity by infrared counts of all animal
movement at 3 weeks of HFD feeding (11 weeks old) and at 7 weeks of
HFD feeding (15 weeks old). Body composition by MRI was measured 3
days before mice were placed in metabolic cages for 96 h, and the first
24 h of measurement were excluded from data analysis while the mice
acclimated. The resulting EE values and RER were calculated from
these measurements. These experiments were conducted in two runs
of mice in subsequent 5-day increments and data is adjusted for run
(n ¼ 7 per run; 3e4 mice per genotype per run).
At 9 weeks on diet (17 weeks old), a glucose tolerance test (GTT) was
performed. 1 mg/kg body weight was injected intraperitoneally after a
6-hour morning fast, blood glucose was measured from the tail vein at
4 time points by glucometer, and a minimal amount of blood was
collected at each time point for subsequent serum insulin analysis. At
11 weeks on diet (19 weeks old), an insulin tolerance test (ITT) was
performed. 0.75 units of insulin/kg body weight was injectedhis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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intraperitoneally after a 6-hour morning fast, and blood glucose was
measured from the tail vein at six time points by glucometer.
Mice were sacrificed under Isoflurane by cardiac puncture at 20 weeks
old (12 weeks on diet) and blood was collected by cardiac puncture,
tissues were dissected, weighed, and snap frozen for analysis; or were
fixed in zinc formalin, embedded in paraffin, and sectioned for histo-
logical analysis; or gWAT was used to isolate adipocytes as described
below.
2.3. Serum biochemistry
At the time of sacrifice after a 6-hour morning fast, whole blood
glucose measurements were made by glucometer (One Touch Ultra
Blue, LifeScan, Inc). Serum from blood obtained at necropsy was
removed after of low speed centrifugation. Insulin was determined by
ELISA (Ultra-sensitive mouse insulin, Crystal Chem, Inc), and FFA was
determined using a colormetric kit (Wako Diagnostics). Total TAG
(glycerol phosphate oxidase, Beckman Coulter OSR6133) and total
cholesterol (Aminoantipyrine/Phenol/Peroxidase, Beckman Coulter
OSR6116) by enzymatic colorimetric endpoint assay (Beckman Coulter
AU400).
2.4. Adipocyte isolation
Gonadal adipose fat pads were dissected from the mouse, weighed,
and immediately submerged in Krebs-Ringer bicarbonate (KRB) buffer
at pH 7.4 with 4% bovine serum albumin (BSA), 500 nM adenosine, and
5 mM glucose, and primary adipocytes were isolated by collagenase
digestion (1 mg/mL KRB) as previously described [27,28]. For mice fed
LFD, fat pads from 2 to 3 mice per genotype were pooled to obtain
enough cells for subsequent experiments. Cells were filtered through a
250-mm nylon mesh and washed. Adipocytes were washed an addi-
tional two times in KRB, then used for subsequent ex vivo experiments
or added to a tube with silicon oil and centrifuged at 10,000g for 2 min,
which separates KRB (bottom) from the adipocytes (top), and adipo-
cytes were removed and frozen at 80 C in Triazol for subsequent
RNA analysis, in 10% SDS for western Blot, or in Med1 buffer for ACSL
activity assay (described below). Fat cell number was determined by the
method described by Goldrick where average cell diameter, determined
using ImageJ software (NIH), is used to calculate fat cell volume, which
can then be multiplied by triglyceride density to calculate the average
fat cell weight [29].Then, total neutral lipid was measured as previously
described [30]. Finally, fat cell number was calculated by the total lipid
content divided by the average fat cell weight [29].
2.5. Ex vivo isolated adipocyte oxygen consumption
Isolated adipocyte OCR was measured using a Clark-type electrode
digital model 10 controller with a constant stir bar (Rank Brothers) and
was water jacketed to maintain adipocytes at 37 C, and data was
recorded by a PowerLab 4/30 data acquisition system (AD Instruments)
as previously described with modifications [31e33]. The electrode
was pre-calibrated with oxygenated water at 37 C and then with
500 mL oxygenated KRB without cells to detect electrode drift. After the
third wash with KRB as described above, isolated adipocytes were
diluted 1:3 in KRB, and a 500 mL aliquot of adipocytes were transferred
to the electrode chamber and air sealed. Basal respiration was
recorded for 15 min and then NaCN was injected for a final concen-
tration of 1 mM and measured for 10 min to inhibit oxygen con-
sumption. Results were calculated based on the assumption that
oxygenated water contains 225 mmol/l O2, and data were corrected for
electrode drift and normalized for fat cell number calculated as
described above. Isolated adipocytes from one ACSL4floxed and one Ad-
KO littermate were isolated after 12 weeks on diet and oxygenMOLECULAR METABOLISM 9 (2018) 43e56  2018 The Authors. Published by Elsevier GmbH. This is an ope
www.molecularmetabolism.comconsumption measured per day to minimize variability for a total of 4
subsequent days (n ¼ 4 mice/genotype).
2.6. Adipose tissue Acyl-CoAs extraction and quantification
Acyl-CoAs were extracted and analyzed using a modified version of a
previously described method [34]. Briefly, gWAT was ground to a
homogenous powder using a liquid nitrogen-chilled mortar and
pestle. Approximately 30e40 mg (wet mass) of each pulverized
tissue sample was rapidly transferred to a pre-weighed chilled
Eppendorf tube before the addition of extraction solvent and the in-
ternal standard. For acyl-CoAs, 1 ml of extraction solvent was used;
solvent was composed of 1:1 of 100 mM KH2PO4 and organic mixture
(3:1:1 ACN, IPA: Methanol). The internal standard was 20 ng/ml of
C17-CoA. The samples were sonicated on ice, followed by centri-
fugation at 4 C. Clean extract was recovered and dried under a
gentle stream of nitrogen. Dried sample was reconstituted with cold
1:1 (methanol: water) and 10 ml was injected on the LC-MS. Chro-
matographic separations were performed with an Agilent Technolo-
gies (Santa Clara, CA) 1200 HPLC system equipped with a Waters
(MA, USA) Acquity UPLC BEH C18 column (2.1  100 mm, 1.7 mm)
and a 2.1  5 mm VanGuard pre-column using the following
conditions: mobile phase A was 10% acetonitrile, 90% MS water,
mobile phase B was acetonitrile. Both mobile phases contained
15 mM ammonium hydroxide. The gradient program for LC-CoA
started at 0% B which was held for 3 min while LC eluent was
directed to the waste during this period. %B was ramped linearly to
30% B over 3 min, then ramped to 40% B over 6 more minutes, then
held at 100% B for 4 min, after which the column was reconditioned
using 100% A for 6 min. The total run time was 22 min and the flow
rate was 0.25 ml/min. Metabolites were quantified by measuring the
metabolite peak area as a ratio to its 13C internal standard analog and
was normalized to the tissue weight.
2.7. Isolated adipocyte lipidomics
Adipocytes were isolated as described above with two washes with
KRB containing BSA and the final wash with KRB without BSA. Adi-
pocytes with buffer were added to a tube with silicon oil and centri-
fuged at 10,000g for 2 min, then adipocytes were removed
minimalizing amount of silicon oil in the sample, and frozen in liquid
nitrogen and stored at80 C. Shotgun lipidomics analysis of isolated
adipocytes was performed at the Center for Metabolic Origins of Dis-
ease at Sanford Burnham Presbyterian Medical Discovery Institute. The
adipocyte samples were added to 200 mL of PBS in an Eppendorf tube
and were homogenized for 1 min by using a disposable soft tissue
homogenizer. An aliquot of 6 mL was pipetted to determine the protein
content (BCA protein assay kit, Thermo Scientific, Rockford, IL). The
rest of homogenate was accurately transferred into a disposable glass
culture test tube, and a mixture of lipid internal standards was added
prior to lipid extraction for quantification of all reported lipid species.
Lipid extraction was performed by using a modified Bligh and Dyer
procedure as described previously [35]. The aqueous phase solution
was loaded onto a HybridSPE cartridge to recover and enrich lyso
phospholipids [36], and the chloroform phase was evaporated under
nitrogen. Both of the extract from aqueous and organic phases were
re-suspended into a volume of 500 mL of chloroform/methanol (1:1, v/
v) per mg of protein and flushed with nitrogen, capped, and stored
at 20 C for lipid analysis. Part of the extract solution from organic
phase was separately derivatized to determine 4-hydroxyalkenal
species [37], cholesterols [38], diacylglycerol species [39], and non-
esterified fatty acids [40]. For ESI direct infusion analysis, lipid
extract or derivatives were further diluted to a final concentration ofn access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 45
Original Articlew500 fmol/mL, and the mass spectrometric analysis was performed
on a QqQ mass spectrometer (Thermo TSQ QUANTIVA, San Jose, CA)
equipped with an automated nanospray device (TriVersa NanoMate,
Advion Bioscience Ltd., Ithaca, NY). Identification and quantification of
lipid molecular species were performed using an automated software
program [35,41]. Data were normalized per mg of protein.
2.8. ACSL enzyme activity assay
ACSL enzyme specific activity was measured as previously described
[10] in isolated adipocytes homogenized in Medium 1 (Med1) buffer
(10 mM Tris pH 7.4, 1 mM EDTA, 0.25 M sucrose, 1 mM DTT), and
centrifuged at 40,000rpm for 1 h at 4 C to pellet membranes, which
were re-suspended in 250 mL Med1 buffer. BCA assay performed to
determine protein content. ACSL enzyme activity assay performed with
50 mM [1e14C] palmitic acid, 10 mM ATP, and 0.25 mM CoA with
total membrane fractions (1e4 mg protein) [10]. Data were normalized
per micrograms of protein determined by BCA assay.
2.9. Liver triacylglycerol and cholesterol
Liver TAG and cholesterol were determined by modified Folch pro-
cedure [42e44]. Snap frozen, wet liver was homogenized in 2:1
chloroform:methanol with overnight incubation and subsequent
extraction with magnesium chloride; the organic layer was evaporated
under nitrogen at 37 C to complete dryness and saponified by
incubating with ethanolic potassium hydroxide solution at 60 C for 1 h
and adding magnesium sulfate. For TAG, the resultant supernatant
was evaluated for liberated glycerol (Sigma). For cholesterol, the su-
pernatant was evaluated by enzymatic, colormetric kit (Inifinity
Cholesterol Liquid Stable Reagent, Thermo Scientific). Measurements
were made in triplicate per sample and data was normalized by protein
content determined by BCA assay.
2.10. Real-time PCR
Adipose tissue and liver RNA was extracted using Qiagen RNEasy Lipid
Mini kits, and isolated adipocyte RNA was extracted using Qiagen
RNEasy Plus Micro kit according to manufacturer’s instructions. RNA
was quantified and checked for purity using the Nanodrop spectro-
photometer (Nanodrop 1000, Wilmington, DE). cDNA was generated
from equal amounts of RNA, and real-time quantitative PCR was
performed using SYBR Green (Applied Biosystems 7300, Carlsbad,
CA). Fold-changes were calculated as 2eDDCT, with Cyclophilin A
used as the endogenous control. Primer sequences are listed in
Supplementary Table 1.
2.11. Western blot
Isolated adipocyte protein was prepared as previously described where
previously frozen isolated adipocytes in 10% SDS were homogenized
in equal amount of lysis buffer without SDS 0.1 mM Na3VO4, 50 mM
HEPES, 2 mM EDTA, 50 mM NaF, 1 mM benzamidine, 5 mL/mL
Protease Inhibitor (Sigma), ph 7.4, plus red blood cell lysis buffer
(Sigma), then incubated for 1 h at 37 C with vortexing, centrifuged at
14,000g for 10 min at room temperature, and the internatent con-
taining protein between the fat cake and the pellet was removed for
subsequent analysis [45]. Adipose tissue and liver were homogenized
in RIPA buffer with protease (Halt) and phosphatase (PhoStop) in-
hibitors at 100 mg/100 mL and 10 mg/100 mL, respectively. Homog-
enates were centrifuged at 12,400g for 10 min at room temperature,
fat free homogenate removed, and centrifugation repeated to ensure
all fat is removed from sample.
Equal amounts of protein (determined by BCA assay) of the protein
lysates were solubilized and denatured by boiling for 5 min in 1X46 MOLECULAR METABOLISM 9 (2018) 43e56  2018 The Authors. Published by Elsevier GmbH. TSDS solution with 2-mercaptoethanol, which were resolved by
loading into wells of 7.5% polyacrylamide gel (Mini Protean TGX,
BioRad) and run with 1X tris-glycine-SDS buffer, transferred to
nitrocellulose membrane, and blocked with 5% bovine serum al-
bumin in tris-buffered saline with 0.2% tween overnight at 4 C.
For demonstration of the presence or lack of ACSL4 protein content,
an affinity purified antibody generously given to us by Dr. Diana
Stafforni (University of Utah) previously described [46] (1:500
dilution for adipocytes; 1:2,000 for adipose tissue and liver) for
1.5 h at room temperature. The secondary antibody, donkey anti-
rabbit horseradish peroxidase (GE Healthcare UK) was diluted
1:10,000 prior to 1 h membrane incubation at room temperature,
detected by chemiluminescence (Supersignal West Pico, Fisher),
and images captured with a sensitive camera (Fluorchem Q, Alpha
Innotech). Blots were then stripped (Restore Western Blot Stripping
Buffer, Thermo Scientific), blocked overnight, and reprobed for
normalization with 1:1,000 dilution of GAPDH or Actin antibody
raised in rabbit for 1 h at room temperature (Cell Signaling). P53
(Cell Signaling) and UCP1 (AbCam) were detected with a purchased
antibody per manufacturer’s instructions.
2.12. Immunohistochemistry
gWAT was fixed and stained for Mac-2 as previously described [26].
Liver was fixed and stained for hematoxylin and eosin (H&E) as pre-
viously described [47].
2.13. In vitro experiments
Cell culture: 3T3-L1 pre-adipocytes were seeded onto tissue culture
plates in 10% fetal bovine serum (FBS) in DMEM high glucose and no
phenol red (basal medium) and allowed to become confluent.
Following confluence, cells were fed basal medium for an addition 48 h
prior to starting differentiation. Differentiation medium consisted of
dexamethasone (1 uM), rosiglitazone (1 uM), 3-isobutyl-1-
methylxanthine (IBMX) (500 uM), and insulin (10 ug/mL) in the basal
medium. Cells were fed differentiation medium for 2 days, then given
basal media supplemented with 10 ug/mL insulin for an addition 2
days. Cells were fed new basal medium every two days for a total of 8
days post differentiation.
Seahorse metabolic measurements: 3T3-L1 cells were grown and
differentiated in the 96-well culture plate provided with the Sea-
horse XFe96 flux pack. After 8 days differentiation, the cells were
incubated with a modified Seahorse assay medium (MgSO4 0.8 mM,
CaCl2 1.8 mM, NaCl 143 mM, KCl 5.4 mM, NaH2PO4, 0.91 mM,
L-Glutamine 2 mM, glucose 25 mM, pyruvate 1 mM, without any
other amino acids or supplements) for 1 h at 37 C in the absence
of CO2 prior to the Seahorse assay. 4-HNE was diluted to the
various concentrations in phosphate buffered saline (PBS) and
loaded into the Seahorse cartridge along with oligomycin (1 uM),
FCCP (1 uM), Antimycin A and rotenone (15 uM) (Sigma Aldrich).
Measurement of oxygen consumption rate (OCR) were recorded with
a XF96 Seahorse (Agilent).
2.14. Statistical analysis
Data were analyzed using SAS 9.3 (Cary, NC) by two-way ANOVA
with Tukey’s HSD for multiple comparisons (where appropriate) or
repeated measures ANOVA for time series data, unless otherwise
indicated. Gene expression data were analyzed by Student’s t-test
with a Bonferroni adjustment for the appropriate number of com-
parisons. Data were expressed as mean  standard error of the
mean. Differences at values of p  0.05 were considered
significant.his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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3. RESULTS
3.1. Generation of mice that lack ACSL4 specifically in adipocytes
Mice with loxP sequences inserted in introns flanking exons 3 and 4 in
the ACSL4 gene were mated to mice expressing a Cre transgene driven
by the Adiponectin promoter [B6; FVB-Tg (Adipoq-cre)1Evdr/J; Jackson
Laboratories, Bar Harbor, ME] [24] to generate adipocyte-specific
Acsl4 knockout mice (Ad-KO) [Supplementary Fig. 1]. Littermates
without the Cre transgene (ACSL4floxed) were used as controls. All
experiments were conducted using male mice.
Adipocyte deficiency of ACSL4 was confirmed by dramatically
reduced ACSL4 mRNA and protein expression in adipocytes isolated
from gWAT, whole gWAT subcutaneous adipose tissue (scWAT), and
BAT of Ad-KO mice as compared to ACSL4floxed littermates.
[Figure 1A,B; Supplementary Figs. 2b and c, Supplementary Fig. 5b].
Consistent with the tissue specificity of the Adipoq-Cre transgene, no
differences in ACSL4 mRNA expression were noted in several non-
adipose tissues nor protein expression in the liver of the two lines
of mice [Figure 1A,B].
3.2. Ad-KO mice were protected against diet-induced obesity
To determine the role of adipocyte ACSL4 expression in DIO, both lines
of mice were fed a LFD or a HFD for 12 weeks. On LFD, no differences
in body composition, fat pad weights, serum insulin, TAG, free FA
(FFA), or hepatic TAG levels were observed between the two lines of
mice [Figure 1CeE, 2A, and Table 1]. However, when fed a HFD,
Ad-KO mice gained 16% less body weight compared to controls
[Figure 1C]. MRI measurements of body fat demonstrated that Ad-KO
mice fed a HFD, compared to ACSL4floxed littermates fed a HFD, had a
significant 35% reduction in body fat with only a minimal change in
lean mass after 12 weeks of HFD feeding [Figure 1D,E]. Consistent
with the body composition observations on a HFD, at sacrifice, theFigure 1: Mice that lack ACSL4 specifically in adipocytes are protected against hi
relative to Cyclophilin A in isolated adipocytes and metabolically relevant tissues in 20 w
Student’s t-test. (B) Representative immunoblot against ACSL4 in isolated gonadal adipo
20-week-old males. (C) Body weight, (D) fat mass, and (E) lean mass from 8 to 20 weeks
HFD; #p  0.05 ACSL4floxed LFD vs. HFD, þp  0.05 Ad-KO LFD vs. Ad-KO HFD, and *p 
multiple comparisons. Data represent  SEM.
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w45%, and gWAT adipocyte size was decreased [Figure 2A,B]. BAT
weight was also decreased 35% compared to controls fed HFD
[Figure 2A]. In mice fed HFD, Ad-KO mice had reduced liver weight and
accumulated significantly less liver TAG, but not cholesterol [Table 1].
Serum cholesterol, but not TAG or FFA, was significantly reduced in
Ad-KO mice compared to controls fed a HFD [Table 1].
3.3. Ad-KO mice fed HFD were protected against markers of gWAT
inflammation, adipocyte death, and insulin resistance
We next determined whether ablation of adipocyte ACSL4 protected
against the development of obesity-associated WAT inflammation.
Real-time PCR analysis of gWAT from ACSL4floxed and Ad-KO mice fed
HFD demonstrated that gWAT from Ad-KO mice had significantly
decreased mRNA abundance of macrophage chemotactic factor (MCP-
1) and macrophage markers F4/80 and CD68, consistent with reduced
macrophage content, and CD11c, a marker for dendritic cells which
has been linked to insulin resistance (IR) [48] [Figure 2C]. Additionally,
we observed protection against HFD-induced expression of the cyto-
kine tumor necrosis factor-a (TNF-a) in gWAT from Ad-KO mice fed
HFD [Figure 2C]. Our laboratory has previously documented that
increased rates of adipocyte death and the formation of crown-like
structures (CLS) correlate with gWAT inflammation, systemic IR, and
liver fat content [25,26]. Ad-KO gWAT from mice fed HFD had 67%
fewer CLS compared to gWAT from ACSL4floxed mice fed HFD
(p ¼ 0.059) [Figure 2D,E].
We next investigated measures of glucose and insulin homeostasis.
Fasting glucose did not differ between the two lines of mice fed a
HFD, but Ad-KO mice fed HFD compared to ACSL4floxed littermates
fed HFD had a significant 49% reduction in fasting serum insulin
levels [Table 1] and 34% lower homeostatic model assessment to
determine insulin resistance (HOMA-IR) [Figure 3A]. Additionally,gh fat diet-induced obesity. (A) ACSL4 RNA expression quantified by real-time PCR
eek old males fed LFD. n ¼ 3e7 mice per group; *p  0.05 ACSL4floxed vs. Ad-KO.
cytes, whole gonadal adipose tissue, whole subcutaneous adipose tissue, and liver of
of age in male mice fed LFD or HFD; n ¼ 11e12 mice/group LFD, 28e31 mice/group
0.05 ACSL4floxed HFD vs. Ad-KO HFD; Repeated measures ANOVA with Tukey’s HSD for
n access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 47
Figure 2: Ad-KO mice fed HFD are protected against markers of adipocyte inflammation and cell death. (A) Adipose tissue depot weight determined at time of sacrifice
after 12 weeks on diet. n ¼ 11e12 mice/group LFD, 28e31 mice/group. *p  0.05 ACSL4floxed HFD vs. Ad-KO within diet; #p  0.05 LFD vs. HFD within genotype; Two-way
ANOVA with Tukey’s HSD for multiple comparisons. (B) Isolated average gonadal adipocyte volume at time of sacrifice after 12 weeks on diet. n ¼ 6e12 mice/group; *p  0.0001
ACSL4floxed HFD vs. Ad-KO within diet; #p  0.0001 LFD vs. HFD within genotype; Student’s t-test after log transformation. (C) Gonadal adipose tissue inflammatory genes of
interest mRNA expression quantified by real-time PCR relative to Cyclophilin A. n ¼ 7e8 mice per group. *p < 0.0125 FL vs. KO within diet; #p < 0.0125 LFD vs. HFD within
genotype. Student’s t-test with Bonferroni correction for 4 comparisons. (D) Crown-like structure (arrows) abundance determined by (E) MAC-2 staining in gonadal adipose tissue of
20 week old male mice; n ¼ 3e4 mice/group LFD 12e15 mice/group HFD. #p  0.05 LFD vs. HFD within genotype. Student’s t-test. Data represent  SEM.
Original ArticleAd-KO mice had improved insulin sensitivity as determined by
reduced area under the curve for insulin tolerance tests (ITT)
compared to ACSL4floxed littermates fed HFD [Figure 3B,C]. During a
glucose tolerance test (GTT), Ad-KO mice fed HFD also exhibited
significantly reduced blood glucose levels at 75 and 120 min and
dramatically lower serum insulin at every time point compared to
ACSL4floxed littermates fed HFD [Figure 3D,E]. In summary, consistent
with reduced adiposity, gWAT inflammation, and adipocyte death,
Ad-KO mice fed a HFD, as compared to ACSL4floxed littermates, were
significantly protected against IR [Figure 3].
3.4. Ad-KO mice fed HFD had higher whole-body EE and isolated
adipocyte oxygen consumption
As a first step to determine the mechanisms by which Ad-KO mice
were protected against DIO, EE was determined before changes in lean48 MOLECULAR METABOLISM 9 (2018) 43e56  2018 The Authors. Published by Elsevier GmbH. Tmass occurred, which does not change until week 9e12 of HFD
feeding [Figure 1E]. Notably, after 3 weeks of HFD feeding, differences
were not observed in metabolic rates between ACSL4floxed and Ad-KO
littermates [Figure 4A]. However, after 7 weeks of HFD feeding, rates
of EE were 10% higher in Ad-KO mice as compared to ACSL4floxed
littermates [Figure 4A,B]. Additionally, using multiple linear regression
methods previously described [49,50], we found the most significantly
predictive model after including genotype, body weight, fat mass, lean
body mass, and experimental run order (described in methods) was
energy expenditure (kcal/day/mouse) ¼ 0.076e1.76(Run) þ
0.69(Genotype) þ 0.42 (Lean Mass) [model p < 0.0001; Run
p < 0.0001, Genotype p ¼ 0.06, lean mass p ¼ 0.048]. These al-
terations in EE occurred in the absence of differences in food intake,
activity, respiratory exchange ratio (RER), or lean mass at 7 weeks of
HFD feeding [Figure 4CeE, Figure 1E].his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Table 1 e Ad-KO mice fed HFD are protected against markers of metabolic syndrome and nonalcoholic steatohepatitis
Low-fat diet High-fat diet
ACSL4floxed Ad-KO ACSL4floxed Ad-KO
Serum TAG (mg/dL) 73.1  3.5 72.4  3.7 67.7  2.9 69.3  3.2
Serum cholesterol (mg/dL) 114.4  5.6 111.0  5.6 184.5  4.3b 151.3  4.9b,a
Serum FFA (mmol/L) 360.3  18.0 337.3  19.0 376.1  14.7 337.2  16.5
Serum glucose (mg/dL) 169.7  12.3 196.0  11.1 206.20  17.4b 194.6  18.6
Serum insulin (ng/mL) 0.41  0.052 0.39  0.049 1.84  0.15b 0.93  0.13b,a
Liver weight (grams) 0.934  0.034 0.920  0.034 1.066  0.021b 0.870  0.026b,a
Liver TAG (mg/mg protein) 0.194  0.0469 0.134  0.0469 0.592  0.0524b 0.350  0.0469b,a
Liver cholesterol (mg/mg protein) 35.17  5.56 37.06  5.56 34.02  6.21 45.62  5.56
TAG, cholesterol, FFA, and glucose n ¼ 9e15 mice/group; Insulin 5-10 mice/group; Liver weight n ¼ 11e12 mice/group LFD, 26e31 mice/group HFD; Liver TAG and cholesterol
n ¼ 8 mice/group.
a p  0.05 ACSL4floxed HFD vs. Ad-KO within diet.
b p  0.05 LFD vs. HFD within genotype. Two-way ANOVA with Tukey’s HSD for multiple comparisons.We hypothesized that alterations in gonadal adipocyte oxygen con-
sumption (OCR) could contribute to the differences in EE. To address
this, gWAT adipocytes were isolated from mice, and we determined
OCR using a Clark electrode. In isolated adipocytes from both
ACSL4floxed and Ad-KO mice fed LFD, adipocyte OCR was very low
(data not shown), but OCR was easily measured in adipocytes from
HFD-fed mice. This is consistent with previous studies in mice and
humans demonstrating that obesity is associated with increased white
adipocyte OCR [51,52]. Remarkably, isolated adipocytes from Ad-KO
mice fed HFD had 3.2-fold higher rates of basal OCR in the pres-
ence of glucose compared to adipocytes from ACSL4floxed mice fed
HFD [Figure 4F].
Previous studies have suggested that FA from adipocyte lipolysis can
increase adipocyte OCR [52,53]. Therefore, we measured rates of
lipolysis and total adipocyte fatty acid content in ACSL4floxed and Ad-
KO adipocytes, which did not statistically differ; thus, alterations in
lipolysis or FFA did not contribute to differences in adipocyte OCR
[Supplementary Figs. 4a and b]. Another possible contributor toFigure 3: Ad-KO mice fed HFD are protected against insulin resistance. (A) Homeost
sacrifice after 12 weeks of HFD feeding; n ¼ 14e15 mice/group. (B) Insulin tolerance test
group. Glucose tolerance test (GTT) (D) blood glucose over time and (E) serum insulin ove
insulin. *p < 0.05 ACSL4floxed HFD vs. Ad-KO HFD; Repeated measures ANOVA ITT and
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brite or “brown-like” adipocytes and associated increased uncou-
pling protein 1 (UCP1) expression [54]. However, western blot
analysis of gWAT lysates probed for UCP1 revealed no differences in
protein expression [Figure 4G], and analysis of gene expression
demonstrated no significant differences in Ucp1 and Pgc1a RNA
abundance in scWAT [Supplementary Fig. 2c] or BAT [Supplementary
Fig. 5a]. Therefore, “browning” of white adipocytes was not a
contributor to increased rates of basal OCR in adipocytes from Ad-KO
mice fed HFD.
3.5. Ad-KO mice fed HFD have alterations in adipocyte ACSL
activity, n-6 PUFA fatty acyl-CoA formation, and FFA and
phospholipid composition
Next, we performed studies to elucidate the molecular mechanisms
that protect Ad-KO mice against DIO in isolated adipocytes. First, we
determined that there was no compensation by other ACSL isoforms
due to ACSL4 knockout in adipocytes from mice fed LFD [Figure 5A].atic model assessment to quantify insulin resistance (HOMA-IR) from serum at time of
(ITT) and (C) ITT area under the curve after 11 weeks of HFD feeding; n ¼ 16e19 mice/
r time after 9 weeks of HFD feeding; n ¼ 7e8 mice/group glucose; 5e6 mice/group
GTT, Student’s t-test HOMA-IR and ITT AUC. Data represent  SEM.
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Figure 4: Ad-KO mice on HFD have higher whole-body energy expenditure and isolated adipocyte oxygen consumption without increased UCP1 expression. (A) Energy
expenditure per mouse per day vs. lean mass measured at 3 weeks of HFD feeding (left) and 7 weeks of HFD feeding (right); n ¼ 5e7 mice/group. (B) Energy expenditure per kg
lean mass per at 7 weeks on HFD; n ¼ 5e7 mice/group; *p  0.05 ACSL4floxed HFD vs. Ad-KO; Repeated measures ANOVA. (C) food intake, (D) activity, and (E) respiratory
exchange ratio measured by TSE Metabolic Chambers for 72 h mass in 15 week-old male mice on HFD for 7 weeks; n ¼ 5e7 mice/group. (F) Oxygen consumption in isolated
gonadal adipocytes measured by Clark Electrode in 20 week-old male mice fed HFD for 12 weeks. Rate of basal respiration with 5 mM glucose was measured for 15 min and then
1 mM NaCN added to shut off respiration for 10 min; n ¼ 4 mice/group; **p  0.01 ACSL4floxed HFD vs. Ad-KO HFD; Two-way ANOVA. (G) Representative immunoblot against
UCP1 in gWAT from 20-week-old male mice fed HFD for 12 weeks. Data represent  SEM.
Original ArticleWe found that gWAT ACSL4 mRNA expression increased with
ingestion of a HFD compared to adipocytes from LFD-fed mice
[Figure 5A]. Notably, Ad-KO adipocytes were protected against HFD-
induced increases in ACSL1, -3, and -5 gene expression [Figure 5A],
which may explain, at least in part, our observation that in the
context of HFD-feeding, isolated adipocytes from Ad-KO mice fed
HFD had 56% lower total ACSL activity compared to isolated adi-
pocytes from ACSL4floxed mice fed HFD [Figure 5B]. We also
demonstrated that differences in adipocyte metabolism were not due
to differences in lipogenic or adipogenic gene expression
[Supplementary Fig. 4c].
To specifically investigate ACSL4’s direct actions on the regulation of
acyl-CoA formation in vivo, we examined ACSL4’s effects on long-
chain fatty acyl-CoA levels. Interestingly, 18:2-, 18:3- and 20:4-CoA
concentrations were decreased 41%, 40%, and 52%, respectively,
in gWAT from Ad-KO mice fed HFD compared to ACSL4floxed fed HFD
[Figure 5C]. No differences in gWAT acyl-CoAs were observed between
ACSL4floxed and Ad-KO mice fed LFD [Supplementary Fig. 6]. These
data indicated an interaction between dietary fat and the relative
consequences of ACSL4 activity in vivo for 18:2-, 18:3-, and 20:4-
CoAs in gWAT in the context of DIO.
Lipidomics analysis of isolated adipocytes from the two lines of mice
fed HFD was performed to determine ACSL4’s role in regulating the
fate of specific FA within different lipid classes specifically within
adipocytes. Remarkably, this analysis revealed that adipocytes from
Ad-KO mice fed HFD had a reduced ability to incorporate AA into all
species of PL [Figure 5E]. Several species of PL also had reduced
incorporation of 22:6 into Ad-KO adipocytes as well [Figure 5E].
Interestingly, some species of PL that had reduced AA also had
concomitant increased incorporation of LA, including PE D16:1e18:2
(0.59 nmol/mg protein ACSL4floxed vs. 0.82 nmol/mg protein Ad-KO)50 MOLECULAR METABOLISM 9 (2018) 43e56  2018 The Authors. Published by Elsevier GmbH. Tcompared to PC D16:1e20:4 (0.48 nmol/mg protein ACSL4floxed vs.
0.32 nmol/mg protein Ad-KO), PI 18:0e18:2 (0.13 nmol/mg protein
ACSL4floxed vs. 0.24 nmol/mg protein Ad-KO) compared to PI 18:0e
20:4 (5.80 nmol/mg protein ACSL4floxed vs. 4.32 nmol/mg protein
Ad-KO), and PS 18:1e18:2 (0.13 nmol/mg protein ACSL4floxed vs.
0.24 nmol/mg protein Ad-KO) compared to PS 18:1e20:4
(0.69 nmol/mg protein ACSL4floxed vs. 0.44 nmol/mg protein Ad-KO)
[Figure 5E]. Consistent with these data and the actions of ACSL4 to
“trap” AA within cells [55,56], the FFA pool in isolated adipocytes
had 48% and 44% decreases in 20:4 (62.4 nmol/mg protein
ACSL4floxed vs. 32.2 nmol/mg protein Ad-KO) and the less abundant
22:6 (12.5 nmol/mg protein ACSL4floxed vs. 7.7 nmol/mg protein Ad-
KO), respectively [Figure 5D]. The FA composition of other lipid
classes including TAG, diacylglycerol, and cardiolipin was not altered
between adipocytes from the two lines of mice fed HFD
[Supplementary Table 2].
Notably, other logical pathways of PUFA metabolism, such as the
pattern of oxylipin metabolites, which are defined as oxygenated
metabolites derived from arachidonic and linoleic acid that includes
eicosanoids [57,58], were not altered in gWAT from the two lines of
mice fed HFD [Supplementary Fig. 7]. Analysis of gWAT did not reveal
any significant differences in free metabolites between ACSL4floxed and
Ad-KO mice fed HFD, including metabolites of cyclooxygenase (COX),
lipoxygenase (LOX), and cytochrome p450 enzymes [Supplementary
Fig. 7]. The absolute levels of total oxylipins, which includes both
esterified and free oxylipins, are significantly increased as compared to
levels of free oxylipins (Supplementary Fig. 7, Supplementary Table 3).
Analysis of oxylipin levels revealed that four out of fifty-five total
oxylipins, were identified as significantly different in gWAT from
ACSL4floxed and Ad-KO mice fed HFD; however, these differences were
not consistent with alterations in a specific metabolic pathway ofhis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 5: Ad-KO mice fed HFD have alterations in adipocyte ACSL activity, n-6 PUFA fatty acyl-CoA formation, and FFA and phospholipid composition. (A) ACSL isoform
gene expression in isolated gonadal adipocytes of 20-week old male ACSL4floxed or Ad-KO mice fed LFD or HFD for 12 weeks RNA expression quantified by real-time PCR relative to
Cyclophilin A. n ¼ 5e8 mice per group. *p  0.05 ACSL4floxed vs. Ad-KO within diet; **p  0.0125 ACSL4floxed vs. Ad-KO within diet; #p  0.05 LFD vs. HFD within genotype;
##p  0.0125 LFD vs. HFD within genotype; Student’s t-test. (B) Total ACSL enzyme activity in isolated gonadal adipocytes of 20 week old males fed LFD or HFD for 12 weeks.
n ¼ 4e6 mice/group *p  0.05 ACSL4floxed vs. Ad-KO within diet. Student’s t-test. (C) Long-chain acyl-CoA species determined in gonadal adipose tissue of male ACSL4floxed or
Ad-KO mice on HFD for 12 weeks as determined by two-way ANOVA. *p  0.05 ACSL4floxed vs. Ad-KO within diet; **p  0.0125 ACSL4floxed vs. Ad-KO within diet. n ¼ 7e8 mice/
group. (D) Isolated adipocyte FFA species (no species less than 20 carbons have significant differences) as determined by two-way ANOVA. *p  0.05 ACSL4floxed vs. Ad-KO within
diet; **p  0.0125 ACSL4floxed vs. Ad-KO within diet. n ¼ 6e9 mice/group. (E) Fold-change of isolated adipocyte arachidonic acid, DHA, and linoleic acid phospholipid
species. Significant differences between groups represented in yellow (p  0.05) and italicized (p  0.01) as determined by two-way ANOVA (Black boxes ¼ Species not
detected). n ¼ 6e9 mice/group. Data represent mean  SEM.oxylipin production or pro/anti-inflammatory balance [Supplementary
Fig. 7]. These data strongly suggest that alterations in oxylipin meta-
bolism in gWAT did not contribute to differences between ACSL4floxed
and Ad-KO mice fed HFD. In summary, lipidomics analysis of isolated
adipocytes demonstrated that ACSL4 had a specific role in generating
AA-CoA, which ultimately resulted in incorporation of AA into PL. Ad-
ipocytes from Ad-KO mice fed HFD had reductions in AA in both PL and
FFA pools.
3.6. Adipocytes from Ad-KO mice fed HFD are protected against
increased 4-HNE production, reductions in glutathione-mediated
detoxification gene expression, and 4-HNE mediated p53 activation
One detrimental metabolic fate of PUFA is lipid peroxidation by ROS
and degradation into toxic aldehydes, including 4-HNE [6,59]. Previous
studies have demonstrated that HFD feeding significantly increased 4-
HNE concentrations, particularly in gWAT [60]. Free-radical ROS can
abstract the bisallylic protons on all polyunsaturated lipids, which then
leads to peroxidation. However, increased numbers of unsaturated
double bonds make lipid species more susceptible to peroxidation.
Thus, AA has aw4-fold higher rate of lipid peroxidation than does LA
due to the extra two double bonds [61,62]. In conjunction with reducedMOLECULAR METABOLISM 9 (2018) 43e56  2018 The Authors. Published by Elsevier GmbH. This is an ope
www.molecularmetabolism.comincorporation of AA into PL and FFA pools, lipidomics profiling
demonstrated a significant 32% decrease in 4-HNE concentration in
adipocytes from Ad-KO mice fed HFD compared to controls [Figure 6A].
In addition to reducing AA, which can be metabolized to form 4-HNE,
we also investigated whether adipocyte ACSL4 regulated expression
of genes involved in glutathione-mediated detoxification of lipid
peroxidation products [6]. Of note, isolated adipocytes from Ad-KO
mice fed a HFD had improved glutathione-mediated detoxification
gene expression [Figure 6B]. These genes (GPX3, GSTT2/3, and
GSTA4) are critical for the detoxification of lipid peroxides and a- and
b-aldehydes, such as the lipid peroxidation product 4-HNE [6]. 4-
HNE is detoxified in cells by several pathways, including the for-
mation of adducts with glutathione catalyzed by glutathione-S-
transferases (GST). In particular, glutathione-S-transferase A-4
(GSTA4) detoxification of 4-HNE is a major determinant of intracel-
lular 4-HNE concentrations [6,63,64]. Increased expression of GSTA4
is particularly notable because its expression was upregulated in-
dependent of diet in adipocytes from Ad-KO mice in mice fed both
LFD and HFD [Figure 6B].
4-HNE has also been demonstrated to increase activation of p53
[63,65], a master regulator of the DNA damage response, cell cyclen access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 51
Figure 6: Adipocytes from Ad-KO mice fed HFD are protected against increased 4-HNE production, reductions in glutathione-mediated detoxification gene expression,
and 4-HNE mediated p53 activation. (A) Isolated adipocyte 4-HNE content as determined by two-way ANOVA. *p  0.05 ACSL4floxed vs. Ad-KO within diet. (B) Glutathione-
mediated detoxification genes of interest in isolated gonadal adipocytes of 20-week old male ACSL4floxed or Ad-KO mice fed LFD or HFD for 12 weeks RNA expression quantified by
real-time PCR relative to Cyclophilin A. n ¼ 5e8 mice per group. *p  0.05 ACSL4floxed vs. Ad-KO within diet; **p  0.0125 ACSL4floxed vs. Ad-KO within diet; #p  0.05 LFD vs.
HFD within genotype; ##p  0.0125 LFD vs. HFD within genotype; Student’s t-test with Bonferroni correction for 4 comparisons. (C) p53 downstream target genes in isolated
gonadal adipocytes of 20-week old male ACSL4floxed or Ad-KO mice on LFD or HFD for 12 weeks RNA expression quantified by real-time PCR relative to Cyclophilin A. n ¼ 5e7
mice per group. *p < 0.0125 ACSL4floxed vs. Ad-KO within diet; #p < 0.0125 LFD vs. HFD within genotype; Student’s t-test with Bonferroni correction for 4 comparisons. (D)
Representative immunoblot against p53 and ACSL4 in gonadal adipose tissue from 20-week-old male mice fed HFD for 12 weeks. (E) Oxygen consumption rate (OCR) determined
by XFe96 Seahorse in 3T3-L1 adipocytes with increasing concentrations of 4-HNE treatment represented as a percentage of basal OCR normalized to the control OCR values. n ¼ 8
wells for control and 6e8 wells per treatment. (F) Real-time PCR of p53 downstream target genes in 3T3-L1 adipocytes treated with 50 mM 4-HNE for 6 h. N ¼ 5e6 wells per
treatment; *p  0.05 treatment vs. control; Student’s t-test. Data represent mean  SEM.
Original Articlearrest, and to promote obesity-associated WAT inflammation and IR
[72,73]. Therefore, we then investigated the association of 4-HNE
levels and p53 in adipocytes from Ad-KO mice. RT-PCR analysis of
isolated adipocytes from Ad-KO mice fed HFD, as compared to
ACSL4floxed, demonstrated significantly reduced expression of genes
regulated by p53, including cyclin-dependent kinase inhibitor 1
(CDKN1A or p21) and insulin growth factor binding protein 3 (IGFBP3)
[Figure 6C]. Activation of p53 may be secondary to an increase in its
protein expression, and western blot analysis revealed that gWAT from
Ad-KO mice fed HFD also had decreased p53 expression compared to
controls fed HFD [Figure 6D]. We also noted that ACSL4 adipocyte
deficiency also reduced HFD-induced increases in expression of
Cdkn1a in subcutaneous adipose tissue [Supplementary Fig. 2e].
These data suggest that ACSL4 ablation, in the context of DIO, is
associated with protection against p53 activation and its downstream
effects on inflammation.
To confirm that 4-HNE can activate p53 in adipocytes, we found that
incubation of 3T3-L1 adipocytes for 6-hours with 4-HNE increased
Cdkn1a mRNA levels 2.9-fold (p ¼ 0.003) and Igfbp3 mRNA
expression approached significance (p ¼ 0.066), consistent with
downstream p53 activation [Figure 6F]. Previously, we noted that
after HFD feeding for 7 weeks, Ad-KO mice were protected against a
reduction in systemic EE that was observed in ACSL4floxed littermates
[Figure 4A] and subsequently we demonstrated that isolated adipo-
cytes from Ad-KO mice had 3.2-fold higher basal OCR compared to
adipocytes from ACSL4floxed mice [Figure 5A], suggesting that al-
terations in adipocyte OCR may contribute to the observed differ-
ences in systemic EE. Since previous studies have demonstrated that
incubation of mitochondria or other non-adipocyte cells with 4-HNE
reduced OCR [66,67] and knockdown of GSTA4 in 3T3-L1 adipo-
cytes reduced adipocyte OCR as well [68], we were led to hypoth-
esize that the increased levels of 4-HNE in ACSL4floxed adipocytes
may depress OCR. To directly investigate this hypothesis, we incu-
bated 3T3-L1 adipocytes with increasing concentrations of 4-HNE for
6 h and observed a dose-dependent decrease in adipocyte OCR52 MOLECULAR METABOLISM 9 (2018) 43e56  2018 The Authors. Published by Elsevier GmbH. Twhere adipocyte OCR was reduced up to 70% compared to control
with 50 mM 4-HNE treatment (in the absence of cell death as
determined by XTT assay data not shown) [Figure 6E]. In summary,
in vitro incubation of adipocytes with increasing concentrations of 4-
HNE reduced adipocyte OCR and increased p53 activation. These
studies are consistent with a role for 4-HNE in activating p53 and
directly reducing gWAT adipocyte OCR in ACSL4floxed adipocytes that
have ACSL4 expression compared to adipocytes from Ad-KO mice
that do not have ACSL4 expression.
4. DISCUSSION
While many studies have focused on the detrimental role of saturated
fatty acids [69], most HFDs also include high dietary PUFA as well, but
we have a more limited understanding of the role of n-6 PUFA, such as
LA, which can be converted within the cells of the body into AA.
Presently, we have a limited understanding of the role of cellular AA, in
the modulation of obesity-associated adipocyte dysfunction. Previous
in vitro studies have suggested that ACSL4 has a preference for
activating AA to form AA-CoA, effectively “trapping” AA within cells,
which can then be directed to incorporation into PL and TAG
[17,56,70]. Additionally, oxylipin metabolites of AA, including prosta-
glandins, leukotrienes, and epoxyeicosatrienoic acids (EET), have been
implicated in adipose tissue inflammation [5]. In addition to serving as
a precursor for eicosanoid synthesis, AA incorporated into PL can
undergo lipid peroxidation, ultimately resulting in toxic lipid peroxida-
tion products, including 4-HNE [6,62]. Interestingly, recent studies
have demonstrated that lipid peroxidation of AA incorporated into PL
specifically by ACSL4 mediates ferroptosis, an iron-dependent non-
apoptotic mode of cell death [19e21].
Here, we have demonstrated that, in the context of HFD feeding,
expression of ACSL4 in adipocytes of mice was significantly increased
[Figure 5A] and determined to be a critical regulator of AA incorporation
into PL [Figure 5E], which is consistent with prior in vitro studies
[20,21,56,70]. Notably, we found that adipocyte ACSL4 expressionhis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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regulated adipocyte OCR and systemic EE in mice on a HFD. Also, we
made the novel observation that ACSL4 expression also regulates
levels of the lipid peroxidation product 4-HNE [Figure 6A], and ulti-
mately, the development of DIO-associated adipocyte dysfunction.
Cellular levels of 4-HNE are regulated by both the rate of formation of
4-HNE from PUFA, including LA and AA, and detoxification of 4-HNE by
GSTA4, a major determinant of intracellular 4-HNE concentrations
[65,71,72]. Since adipocytes from Ad-KO mice fed HFD had reduced
cellular levels of AA [Figure 5D,E] as well as increased expression of
GSTA4 [Figure 6B], adipocytes from Ad-KO mice fed HFD possess the
two aforementioned complementary pathways to reduce cellular 4-
HNE concentrations. These observations are important because pre-
vious studies in cultured adipocytes demonstrated that knockdown of
GSTA4 resulted in increased lipid peroxidation, mitochondrial oxidative
stress, and reduced adipocyte OCR [68,71], which significantly par-
allels our in vivo observations of adipocytes from ACSL4floxed mice fed
HFD but not in adipocytes from Ad-KO mice fed HFD. Also, of related
interest, genetic disruption of GSTA4 in mice resulted in increased
adipose tissue levels of 4-HNE, obesity, and WAT inflammation [72].
Interestingly, adipocytes of Ad-KO mice fed a HFD were at least
partially protected against the increased mRNA expression of two
additional ACSL isoforms, ACSL3 and ACSL5, whose expression could
also contribute to obesity-associated adipocyte dysfunction.
In the obese state, there is increased production of ROS in gWAT of
mice [73], which likely contributes to the documented increased
concentrations of toxic aldehydes in gWAT, including 4-HNE [60]. Both
20:4 (AA) and 22:6 (DHA) PUFA contain bis-allylic groups where a
methylene group is located in between two double bonds, and are
oxidized and undergo lipid peroxidation at 2e3 times the rate per bis-
allylic bond compared to 18:2 (LA) PUFA [61,62]. Thus, even though
18:2 content was not reduced in the PL of adipocytes from Ad-KO mice
fed HFD, the reduction of 20:4 content, and corresponding reduction of
reactive bis-allylic protons, in adipocyte PL, from Ad-KO mice fed a
HFD may explain, in part, the reduction in 4-HNE. An alternative but
related potential mechanism for the role of ACSL4 in adipocyte
dysfunction, under investigation in our laboratory, comes from studies
which have found that the lipid peroxidation of PL-AA in ferroptosis
occurs secondary to the actions of a lipooxygenase [21].
Adipocyte OCR is regulated in many complex ways as was demon-
strated in previous studies [31,52]. Remarkably, our data demon-
strated that adipocytes from Ad-KO mice chronically fed HFD for 12
weeks had significantly reduced levels of 4-HNE and increased rates of
adipocyte OCR compared to adipocytes from ACSL4floxed mice
[Figure 4F]. We hypothesized that the alterations in adipocyte OCR is a
significant contributor to our observation that with HFD feeding, Ad-KO
mice were protected against a reduction in systemic EE that was noted
in ACSL4floxed mice [Figure 4A].
We also observed that adipocyte expression of ACSL4 was associated
with increased activation of p53, which we hypothesized was due to
the increased 4-HNE levels [Figure 6C,D]. Consistent with these pre-
viously published studies, we incubated 3T3-L1 adipocytes with 4-HNE
that resulted in a 2.86-fold increase in Cdkn1a mRNA expression
(p¼ 0.009) [Figure 6F]. Importantly, increased activation of p53 within
adipocytes of mice has been demonstrated to increase both WAT
inflammation and IR [74,75], which is consistent with our observations
of reduced p53 expression, WAT inflammation, and IR.
A necessary question that stems from our observations is how spe-
cifically does adipocyte PL remodeling result in alterations in 4-HNE
levels and adipocyte dysfunction. We hypothesize that one possible
scenario to explain the phenotype of Ad-KO mice fed a HFD is that
ablation of ACSL4 expression in adipocytes reduced the availability ofMOLECULAR METABOLISM 9 (2018) 43e56  2018 The Authors. Published by Elsevier GmbH. This is an ope
www.molecularmetabolism.comcellular AA that can be converted into 4-HNE secondary to associated
increases in oxidative stress. In the adipocytes from ACSL4floxed mice
(control mice), increased concentrations of 4-HNE contributed to
adipocyte dysfunction through several potential pathways, including
activation of p53, redox potential, and inflammation, including the
production of cytokines such as TNF-a. It is also known that incubation
of cultured adipocytes with TNF-a reduces GSTA4 mRNA expression
[71]. Thus, in addition to reduced substrate for lipid peroxidation,
adipocytes from Ad-KO mice fed HFD also had reduced TNF-a
[Figure 2C] and higher levels of GSTA4 expression [Figure 6B], which
suggests an improved ability to detoxify 4-HNE from adipocytes.
Additionally, we hypothesized that increased levels of 4-HNE resulted
in altered mitochondrial function and reduced adipocyte OCR. Pro-
tection against increased levels of adipocyte 4-HNE may then protect
against activation of p53, WAT inflammation, and reductions in
adipocyte OCR.
The phenotypic improvements of ACSL4 ablation on DIO in our mice
are highlighted by the observation that reductions in body weight of
obese humans with metabolic complications, as modest as 5%, pro-
gressively improve systemic IR, intra-abdominal adipose tissue mass,
and hepatic steatosis [76]. Since TZDs have been demonstrated to
potently block the catalytic activity of ACSL4 by a non-PPARg mech-
anism, our results document a potentially novel mechanism by which
this class of drugs may possibly act to ameliorate adipocyte
dysfunction [11,12]. Importantly, and of translational interest, in
various micro-array studies in humans, ACSL4 expression in adipose
tissue and/or adipocytes has been demonstrated to be increased with
obesity and IR [77,78].
5. CONCLUSIONS
In conclusion, this study documents the first in vivo elucidation of
ACSL4’s actions. It is critical to note that ACSL4 represents a small
fraction of total ACSL expression in adipocytes, but eliminating its
contribution, in the context of DIO, resulted in major whole-body
physiological effects. Adipocyte ACSL4 regulates AA incorporation
into PL, which is highly susceptible to peroxidation, and forms
detrimental products, such as 4-HNE. By reducing the incorporation
of AA into PL and FFA pools in adipocytes, Ad-KO mice were
significantly protected against HFD-induced increases in adipose
and liver fat accumulation, adipocyte death, gWAT inflammation,
and IR. Additionally, deficiency of adipocyte ACSL4 expression
in mice fed a HFD increased adipocyte OCR, which we demon-
strated are direct effects of 4-HNE on adipocytes in vitro, and whole
body EE.
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